Every year, the ACB Scientific Committee is charged by the ACB Council to give financial support to young scientists in the profession undertaking relevant research. There is a sum of money budgeted for this purpose. Applications normally open in May and close at the end of August. Scholarships are awarded at the September meeting of the Scientific Committee.
2020 Round - COVID-19 Scholarship Programme supported by Abbott
In response to the global pandemic, the ACB’s scholarship programme was enhanced and accelerated to support rapid innovation related to COVID-19.
ACB sought innovative scientists to develop rapid scientific research projects that improve the care of COVID-19 patients. There was a total of £50,000 scholarship funds available with a limit for each application of £20,000.
Assessors of applications were looking for:
- A clear vision of how the project could improve the care of COVID-19 patients
- Scientific research and innovation projects that are pan-pathology and/or multi-disciplinary
- Potential for industry partnership which could include existing partnership(s)
- A timetable of costs and activity indicating when funds will need to be drawn down within a twelve-month period
- Development pathway for the project to further stages of funding and partnership
- A commitment to share learning and demonstrate progress at meetings and via appropriate media channels
- All ACB members are eligible to apply however early career grade members are particularly encouraged to apply.
In addition to funding, ACB will offer access to expert advice and mentoring to support successful projects on the development journey beyond the initial funding. This could include such support as:
- Introductions to further grants/funders
- Support with proposals and bids
- Skills support for presentations, media, communications
- Business planning and budgeting advice
- Attendance and presentations of selected project(s) at relevant ACB meetings such as FOCUS & Frontiers in Laboratory Medicine (FiLM).
Contact the ACB team for further information
- Charlotte Armitage - Association of progesterone and its neurosteroid metabolite, allopregna-nolone, with inflammation in patients with perinatal depression
- Julie Tarling - Prognostic value of kisspeptin as a biomarker to distinguish between miscarriage and viable pregnancies.
- Karen Perkins - Development of a tandem mass spectrometry method for biotin measurement to investigate biotin interference in immunoassays for biomarkers of placental dysfunction.
- Caroline Hyam - Prevalence of macrotroponin in patients with elevated cardiac troponin I using the Siemens Advia Centaur® high sensitivity method.
- Christopher McClean - Investigating the co-abuse of antidepressants by patients monitored by drugs of abuse using tandem mass spectrometry.
- Joseph Taylor - Assessing pre-analytical factors and optimisation of analytical conditions to facilitate study of the metabolome associated with adrenal incidentaloma using high-resolution accurate-mass mass spectrometry.
- Melissa McNaughton - Development of a liquid chromatography-tandem mass spectrometry assay for antihypertensive drugs in urine
- Rebecca Dewar - Improving accuracy and speed of respiratory infection diagnosis in paediatric intensive care by real-time sequencing
- Victoria Miari - Development and validation of a quantitative molecular viability assay for N. gonorrhoea
- Chris Maynard - Development of an LC-MS method for free thyroxine to investigate interference in routine immunoassays
- Milad Khedr - A stable-isotope study of tyrosine degradation in Alkaptonuria patients, before and after nitisinone, compared to healthy volunteers
- Emma Frith - Biochemical and epigenetic footprints of HPA activation in pregnancies complicated with antenatal depression and associated comorbidities